HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

This Week in 340B: December 6 – 20, 2023

By and on December 21, 2023
Posted In 340B

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation.

Issues at Stake: Contract Pharmacy

  • In a case regarding a state law governing contract pharmacy arrangements, plaintiff pharmaceutical company and defendant state attorney general jointly filed a motion to set briefing schedule, whereby both parties agreed to proceed directly to cross-motions for summary judgment.
  • In a case regarding a state law governing contract pharmacy arrangements, defendant state attorney general filed: (1) a cross motion for summary judgment, (2) a statement of material fact to accompany the cross-motion for summary judgment, (3) a combined memorandum in opposition to motion for summary judgment and in support of cross motion for summary judgment, (4) a response to plaintiff pharmaceutical company’s statement of material facts. In the same case, a state primary care association joined as an intervenor-defendant and filed the following: (1) a cross motion for summary judgment on all of plaintiff pharmaceutical company’s claims and in opposition to plaintiff pharmaceutical company’s motion and opposition, (2) a memorandum of law in support of intervenor-defendant’s cross motion for summary judgment on all claims and in opposition to plaintiff’s motion for summary judgment on preemption claims, (3) a statement of material facts in support of intervenor-defendant’s cross motion, and (4) a response to plaintiff pharmaceutical company’s statement of material facts
  • In a separate case regarding a state law governing contract pharmacy arrangements, defendant state attorney general filed: (1) a cross motion for summary judgment, (2) a statement of material fact to accompany the cross-motion for summary judgment, (3) a combined memorandum in opposition to motion for summary judgment and in support of cross motion for summary judgment, (4) a response to plaintiff pharmaceutical company’s statement of material facts. In the same case, a state primary care association joined as an intervenor-defendant and filed the following: (1) a cross motion for summary judgment on plaintiff pharmaceutical company’s preemption and vagueness claims and in opposition to plaintiff pharmaceutical company’s motion, (2) a memorandum of law in support of intervenor-defendant’s cross motion for summary judgment and in opposition to plaintiff’s motion for summary judgment, (3) a statement of material facts in support of intervenor-defendant’s cross motion, and (4) a response to plaintiff pharmaceutical company’s statement of material facts. The court then set forth a notice of motion setting for the parties.

Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker, a subscription product from McDermott+Consulting.

Emily Jane Cook
Emily Cook is a practice area leader for McDermott's Healthcare Regulatory & Compliance practice. She is a national authority on the 340B drug pricing program, and also helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. Learn more about Emily's practice here.


Patrick Moore
Patrick Moore is an associate in McDermott's Healthcare Practice Group. While earning his law degree, Patrick served as a legal intern for a global life sciences research organization and as managing editor of the Journal of International Law and Foreign Affairs at UCLA School of Law.Learn more about Patrick's practice here.

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm